Mechanistically, in renal cell carcinoma, the abundance of ROS inhibits the P300/CBP-associated factor (PCAF)-dependent acetylation of PKM2 the lysine residue 305 site (K305), contributing to ETOP resistance (Shanmugasundaram et al. 2017). Here, KAT2B is linked to hereditary clear cell renal cell carcinoma.